§FMCSR.com
Historical textIn force on June 1, 2015Source: annual CFR editions 2010–2016

Appendix C to Part 40 Appendix C to Part 40 - DOT Drug Testing Semi-Annual Laboratory Report to DOT

Wording in the annual edition revised as of Oct. 1, 2010, superseded November 13, 2017.

govinfo, 2014 edition ↗
Before Jan. 1, 2017 the record is one snapshot per annual CFR edition, revised as of October 1. This is the 2014 edition's wording. An amendment that took effect between Oct. 1, 2014 and June 1, 2015 would not appear until the next edition, so check the citations below and the Federal Register for exact effective dates.
What changedOct. 1, 2008 wording → Oct. 1, 2010 wording+68 added−7 removedHide

Mail, fax, or e-mail to: U.S. Department of Transportation, Office of Drug and Alcohol Policy and Compliance, W62-300, 1200 New Jersey Avenue, SE., Washington, DC 20590,. Fax: (202) 366-3897,. E-mail: ODAPCWebMail@dot.gov.
The following items are required on each report:
Reporting Period: (inclusive dates)
Laboratory Identification: (name and address)
1. DOT Specimen Results Reported (total number)
2. Negative Results Reported (total number)
Negative (number)
Negative-Dilute (number)
3. Rejected for Testing Results Reported (total number)
By Reason
(a)
Fatal flaw (number)
(b) Uncorrected Flaw (number)
4. Positive Results Reported (total number)
By Drug
(a)
Marijuana Metabolite (number)
(b) Cocaine Metabolite (number)
(c) Opiates (number)
(1) Codeine (number)
(2) Morphine (number)
(3) 6-AM (number)
(d) Phencyclidine (number)
(e) Amphetamines (number)
(1) Amphetamine (number)
(2) Methamphetamine (number)
(3) MDMA (number)
(4) MDA (number)
(
5) MDEA (number)
5
. Adulterated Results Reported (total number)
By Reason (number)
6. Substituted Results Reported (total number)
7. Invalid Results Reported (total number)
By Reason (number)
[7375 FR 3597549864, JuneAug. 2516, 20082010]

Mail, fax, or e-mail to: U.S. Department of Transportation, Office of Drug and Alcohol Policy and Compliance, W62-300, 1200 New Jersey Avenue, SE., Washington, DC 20590. Fax: (202) 366-3897. E-mail: ODAPCWebMail@dot.gov.

The following items are required on each report:

Reporting Period: (inclusive dates)

Laboratory Identification: (name and address)

1. DOT Specimen Results Reported (total number)

2. Negative Results Reported (total number)

Negative (number)

Negative-Dilute (number)

3. Rejected for Testing Results Reported (total number)

By Reason

(a) Fatal flaw (number)

(b) Uncorrected Flaw (number)

4. Positive Results Reported (total number)

By Drug

(a) Marijuana Metabolite (number)

(b) Cocaine Metabolite (number)

(c) Opiates (number)

(1) Codeine (number)

(2) Morphine (number)

(3) 6-AM (number)

(d) Phencyclidine (number)

(e) Amphetamines (number)

(1) Amphetamine (number)

(2) Methamphetamine (number)

(3) MDMA (number)

(4) MDA (number)

(5) MDEA (number)

5. Adulterated Results Reported (total number)

By Reason (number)

6. Substituted Results Reported (total number)

7. Invalid Results Reported (total number)

By Reason (number)

[75 FR 49864, Aug. 16, 2010]

Amendment history

5 distinct wordings on file since Oct. 1, 2008
  1. [82 FR 52247, Nov. 13, 2017]
  2. [82 FR 52247, Nov. 13, 2017]
  3. [75 FR 49864, Aug. 16, 2010]
  4. Oct. 1, 2010 → Nov. 13, 2017annual editions 2010–2016diff vs. previousviewing
    [75 FR 49864, Aug. 16, 2010]
  5. Oct. 1, 2008 → Oct. 1, 2010annual editions 2008–2009
    [73 FR 35975, June 25, 2008]

A new entry appears whenever the regulatory words change between government snapshots. Day-precise from the eCFR (2017 onward); before that, one snapshot per annual CFR edition (revised as of October 1). Bracketed citations are the Federal Register history printed with the section.